Detalhe da pesquisa
1.
CD276 as a Candidate Target for Immunotherapy in Medullary Thyroid Cancer.
Int J Mol Sci
; 24(12)2023 Jun 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37373167
2.
A Significance of Concomitant BRAFV600E and TERT Mutations in Polish Patients with Papillary Thyroid Microcarcinoma: A Retrospective Cohort Study Based on 430 Cases.
Thyroid
; 32(11): 1372-1381, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-35950639
3.
Are molecular tests necessary to diagnose NIFTP?
Genes Cancer
; 12: 39-50, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33884105
4.
Immune Profiling of Medullary Thyroid Cancer-An Opportunity for Immunotherapy.
Genes (Basel)
; 12(10)2021 09 28.
Artigo
Inglês
| MEDLINE | ID: mdl-34680929
5.
Immunohistochemistry cannot replace DNA analysis for evaluation of BRAF V600E mutations in papillary thyroid carcinoma.
Oncotarget
; 8(43): 74897-74909, 2017 Sep 26.
Artigo
Inglês
| MEDLINE | ID: mdl-29088832